Reading LMNR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LMNR free→Reading LMNR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LMNR free→NASDAQConsumer StaplesFarm ProductsSnapshot 2026-06-12
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and the company was unprofitable over the past year, so its earnings quality can't be assessed. Management's recent track record has been steady, but risk is elevated, and the sector backdrop is a headwind. Compared with sector peers, LMNR trades below typical levels. Peer multiples imply a price about 133% below where it trades (it looks expensive on this basis); the read is rich. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 1 valuation methods, at three horizons. Current price $12.96. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $13 LMNR trades at 2× p/s — 2.3× the 1× p/s peer median. The market is re-rating it beyond its own range; our $5.60 fair value is low-confidence here. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 131% near-term growth, well above our forecast of about -23%. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Only expensive valuation — not the full expensive x weak x turbulent stack.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated weak grew net income 56% of the time over the next year (vs 58% for the rest of the cohort, n=1144).
Over the trailing year it converted 0.45x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.17 → $0.17 (+0.0% / 30d). 0 raised, 1 cut, 3 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 67% of analysts rate Buy.
1 PT revisions / 30d. Avg target 49.4% above current price.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$85.
How much price usually moves either way.
On a bad day, this stock has moved -$286.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,760.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
risk label changed from 'moderate' to 'elevated'.
Risk rose. The risk label changed to "elevated." Earnings quality remains weak. The sector backdrop is a headwind. Recent financial performance is also weak.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
No named catalysts to watch right now. Check back after the next earnings report.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for LMNR yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition On June 9, 2026, Limoneira Company (NASDAQ: LMNR) issued a press release announcing its financial results for the quarter ended April 30, 2026. A copy of the press release is furnished within this report as Exhibit 99.1.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
A side-by-side read on sector standing, valuation, and risk versus Agricultural Products & Services.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
LMNR Limoneira Co. | Below typical Show detailsSector percentile: 1 of 100 | expensive | elevated |
ADM Archer Daniels Midland | Above typical Show detailsSector percentile: 77 of 100 | full | moderate |
BG Bunge Global | Above typical Show detailsSector percentile: 97 of 100 | fair | moderate |
DAR Darling Ingredients | Typical Show detailsSector percentile: 53 of 100 | expensive | moderate |
INGR Ingredion | Typical Show detailsSector percentile: 63 of 100 | inexpensive | moderate |
Not investment advice. As of 2026-06-12.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
The company has increased its avocado volume guidance for fiscal year 2026.
The company continues to maintain a dividend of $0.075 per share.